Agency
National Institute of Health (NIH)
Institute
National Institute of Mental Health (NIMH)
Type
Research Project (R01)
Project #
5R01MH052527-02
Application #
2252309
Study Section
Special Emphasis Panel (SRCM (01))
Project Start
1994-12-01
Project End
1999-11-30
Budget Start
1995-12-15
Budget End
1996-11-30
Support Year
2
Fiscal Year
1996
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Physiology
Type
Schools of Dentistry
DUNS #
004514360
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Haddox, J L; Pfister, R R; Sommers, C I et al. (2001) Inhibitory effect of a complementary peptide on ulceration in the alkali-injured rabbit cornea. Invest Ophthalmol Vis Sci 42:2769-75
Xu, L; Villain, M; Galin, F S et al. (2001) Prevention and reversal of experimental autoimmune myasthenia gravis by a monoclonal antibody against acetylcholine receptor-specific T cells. Cell Immunol 208:107-14
Su, Z; Csutora, P; Hunton, D et al. (2001) A store-operated nonselective cation channel in lymphocytes is activated directly by Ca(2+) influx factor and diacylglycerol. Am J Physiol Cell Physiol 280:C1284-92
Houtman, R; Ten Broeke, R; Blalock, J E et al. (2001) Attenuation of very late antigen-5-mediated adhesion of bone marrow-derived mast cells to fibronectin by peptides with inverted hydropathy to EF-hands. J Immunol 166:861-7
Araga, S; Xu, L; Nakashima, K et al. (2000) A peptide vaccine that prevents experimental autoimmune myasthenia gravis by specifically blocking T cell help. FASEB J 14:185-96
Pfister, R R; Haddox, J L; Blalock, J E et al. (2000) Synthetic complementary peptides inhibit a neutrophil chemoattractant found in the alkali-injured cornea. Cornea 19:384-9
Manion, M K; Villain, M; Pan, Z G et al. (2000) Cellular uptake and in situ binding of a peptide agonist for calmodulin. Biochem Biophys Res Commun 277:462-9
Villain, M; Jackson, P L; Manion, M K et al. (2000) De novo design of peptides targeted to the EF hands of calmodulin. J Biol Chem 275:2676-85
Manion, M K; Su, Z; Villain, M et al. (2000) A new type of Ca(2+) channel blocker that targets Ca(2+) sensors and prevents Ca(2+)-mediated apoptosis. FASEB J 14:1297-306
Blalock, J E (1999) Proopiomelanocortin and the immune-neuroendocrine connection. Ann N Y Acad Sci 885:161-72

Showing the most recent 10 out of 16 publications